Artificial intelligence is set to revolutionise fertility treatments thanks to a new tool, T’easy, developed by researchers at the UZ Brussel fertility clinic and Robovision Healthcare, which enhances the detection of sperm in semen.
This innovative system combines an application, a customised microscope, and AI to automatically and swiftly identify sperm in testicular tissue biopsies, particularly benefiting men with low sperm count. The identified tissue is then used in in vitro fertilisation (IVF), where a single sperm is injected directly into an egg.
Traditional methods may struggle to locate sperm, but T’easy can identify sperm within ten minutes, providing crucial support in challenging cases.
“T’easy allows us to detect sperm more quickly and accurately, giving parents a faster understanding of their fertility treatment’s chances of success,” states the university hospital. “Additionally, it lowers the risk of missing usable sperm.”
This advancement saves considerable time for healthcare providers, as manual sperm detection in testicular tissue is often labour-intensive and demands specialised personnel due to the rarity and difficulty of finding sperm in this tissue.
For now, T’easy will remain in the research phase.
